4-Methylmorpholine → HCID 58546825, compound
Reaction equation
[CH3:1][N:2]1[C:6]2[CH:7]=[CH:8][CH:9]=[CH:10][C:5]=2[N:4]=[C:3]1[C:11]([OH:13])=O.Cl.[NH:15]1[CH2:18][CH:17]([C:19]2[C:24]([Cl:25])=[N:23][CH:22]=[CH:21][N:20]=2)[CH2:16]1.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.CN1CCOCC1>CN(C=O)C.O>[Cl:25][C:24]1[C:19]([CH:17]2[CH2:18][N:15]([C:11]([C:3]3[N:2]([CH3:1])[C:6]4[CH:7]=[CH:8][CH:9]=[CH:10][C:5]=4[N:4]=3)=[O:13])[CH2:16]2)=[N:20][CH:21]=[CH:22][N:23]=1Participants
8
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 1-methyl-1H-benzoimidazole-2-carboxylic acid (82) (176 mg, 1.0 mmol), 2-Azetidin-3-yl-3-chloro-pyrazine hydrochloride (8) (169 mg, 1.0 mmol), HOBt (151 mg, 1.2 mmol), EDCI (231 mg, 1.2 mmol) and N-methyl-morpholine (NMM) (300 mg, 3.0 mmol) in DMF (5 mL) was stirred at RT for 24 h. The mixture was diluted with water (20 mL), and filtered. The filter cake was washed with water and dried in vacuo to provide [3-(3-chloro-pyrazin-2-yl)-azetidin-1-yl]-(1-methyl-1H-benzoimidazol-2-yl)-methanone (83) (300 mg, yield 90%).
Workup
- filtrationfiltered
- washThe filter cake was washed with water
- customdried in vacuo
Sources & evidence
- ORD record
- ord-288ce9213f6a4b7188cd6a25e6930c9b
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08957073B2
Reaction notes
Loading…